TrialRheumatology (Oxford, England)2022

Response to secukinumab on synovitis using Power Doppler ultrasound in psoriatic arthritis: 12-week results from a phase III study, ULTIMATE.

Maria Antonietta D'Agostino et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.